Lonafarnib 10-Iodo Impurity - Request Quote
Lonafarnib 10-Iodo Impurity
| SZ CAT No: | SZ-L104010 |
| CAS No | NA |
| Mol.F. | C27H31BrClIN4O2 |
| Mol.Wt. | 685.8 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lonafarnib 10-Iodo Impurity is chemically (R)-4-(2-(4-(3-Bromo-8-chloro-10-iodo-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidin-1-yl)-2-oxoethyl)piperidine-1-carboxamide. Lonafarnib 10-Iodo Impurity is supplied with detailed characterization data compliant with regulatory guideline. Lonafarnib 10-Iodo Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lonafarnib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Lonafarnib 10-Iodo Impurity
Purchase Lonafarnib 10-Iodo Impurity
Lonafarnib 10-Iodo Impurity suppliers
Lonafarnib 10-Iodo Impurity manufacturers
Lonafarnib 10-Iodo Impurity price
Order Lonafarnib 10-Iodo Impurity
Enquire Lonafarnib 10-Iodo Impurity
Lonafarnib 10-Iodo Impurity cost
Lonafarnib 10-Iodo Impurity Supplier
Lonafarnib 10-Iodo Impurity Distributor
Lonafarnib 10-Iodo Impurity for Method Validation
Lonafarnib Reference Standard
Lonafarnib 10-Iodo Impurity for ANDA Filing
Lonafarnib 10-Iodo Impurity for Forced Degradation Studies
Lonafarnib 10-Iodo Impurity Identification Standards
Lonafarnib 10-Iodo Impurity for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.